Cradle is a Dutch-Swiss biotechnology company offering a software platform powered by generative AI for protein engineering and optimization. It helps scientists design, evaluate, and improve protein sequences with much higher efficiency than traditional trial-and-error lab methods.
Engineering proteins — whether for therapeutics, enzymes, bio-based materials, or sustainable food ingredients — traditionally takes years of experimentation and heavy lab costs. Cradle uses machine learning to propose protein variants that meet desired functional objectives, helping teams cut down development time and resource use dramatically.
Users upload experimental data or define their design objectives (e.g., binding strength, stability, expression). Cradle’s generative AI models then learn from this context and propose new protein sequences optimized across multiple properties simultaneously. The platform continually improves by integrating wet-lab validation data and refining predictions.
